Predictive Symptoms and Signs of Laboratory-confirmed Influenza

Medicine (United States)

Volumn 94, Issue 44, 2015, Pages e1952-

  Yang, Jeng How ^a   Huang, Po Yen ^a   Shie, Shian Sen ^a   Yang, Shuan ^b   Tsao, Kuo Chien ^b   Wu, Tsu Lan ^b   Leu, Hsieh Shong ^a   Huang, Ching Tai ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ANTIVIRAL THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COUGHING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A VIRUS; INFLUENZA B; INFLUENZA VACCINATION; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NOSE OBSTRUCTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RHINORRHEA; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TAIWAN; THROAT CULTURE; VIRUS CULTURE; VIRUS ISOLATION; AGED; GENETICS; INFLUENZA, HUMAN; MIDDLE AGED; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

VIRUS DNA;

ADULT; AGED; DNA, VIRAL; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; TAIWAN;

EID: 84965177616     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001952     Document Type: Article

References (37)

1. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swineorigin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615.
2. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197-201.
3. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460:1021-1025.
4. Liu CH, Wang JL, Su CP, et al. Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan. BMC Public Health. 2013;13:646-653.
5. Wu UI, Wang JT, Chang SC, et al. Impacts of a mass vaccination campaign against pandemic H1N1 2009 influenza in Taiwan: a timeseries regression analysis. Int J Infect Dis. 2014;23:82-89.
6. Yen MY. From SARS in 2003 to H1N1 in 2009: lessons learned from Taiwan in preparation for the next pandemic. J Hosp Infect. 2014;87:185-193.
7. Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis [Internet]. 2011;52 (suppl 1): S75-S82.
8. Lehners N, Geis S, Eisenbach C, et al. Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany. Emerg Infect Dis. 2013;19:748-755.
9. Mytton OT, Rutter PD, Donaldson LJ. Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year. Euro Surveill. 2012;17: 20139.
10. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362:1733-1745.
11. Yoon SW, Webby RJ, Webster RG. Evolution and ecology of influenza A viruses. Curr Top Microbiol Immunol. 2014;385:359-375.
12. Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis. 2009;48:e89-92.
13. Brendish NJ, Schiff HF, Clark TW. Point-of-care testing for respiratory viruses in adults: The current landscape and future potential. J Infect. 2015; pii: S0163-4453(15)00233-9.
14. Centers for Disease Control and Prevention. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection. 2015. Available from: http://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm. Accessed September 1, 2015.
15. Carrat F, Tachet A, Rouzioux C, et al. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis. ;28:283-290.
16. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-3247.
17. Woolpert T, Brodine S, Lemus H, et al. Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis. BMC Infect Dis. 2012;12:129-139.
18. Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza JAMA. 2005;293:987-997.
19. Yang JH, Huang PY, Shie SS, et al. Diagnostic capacity of rapid influenza antigen test: reappraisal with experience from the 2009 H1N1 pandemic. J Microbiol Immunol Infect. 2012;45:102-107.
20. R Core Team (2014). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: http://www.R-project.org/.
21. Centers for Disease Control and Prevention. Overview of influenza surveillance in the United States. Available from: http://www.cdc.gov/flu/weekly/overview.htm. Accessed August 12, 2015.
22. Centers for Disease Control, Taiwan. Influenza-like illness: definition for the reporting of Influenza-like illness. Available from: http://www.cdc.gov.tw/english/page.aspxtreeide79c7a9e1e9b1cdf& nowtreeid30a694d1c68e12cb. Accessed August 10, 2015.
23. World Health Organization. WHO surveillance case definitions for ILI and SARI. Available from: http://www.who.int/influenza/surveillance-monitoring/ili-sari-surveillance-case-definition/en/. Accessed August 13, 2015.
24. Boivin G, Hardy I, Tellier G, et al. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166-1169.
25. Jiang L, Lee VJ, Lim WY, et al. Performance of case definitions for influenza surveillance. Euro Surveill. 2015;20:21145.
26. Shah SS, Rumoro DP, Hallock MM, et al. Clinical predictors for laboratory-confirmed influenza infections: exploring case definitions for influenza-like illness. Infect Control Hosp Epidemiol. 2015;36:241-248.
27. Ong AK, Chen MI, Lin L, et al. Improving the clinical diagnosis of influenza: a comparative analysis of new influenza A (H1N1) cases. PLoS One. 2009;4:e8453.
28. Govaert TM, Dinant GJ, Aretz K, et al. The predictive value of influenza symptomatology in elderly people. Fam Pract. 1998;15:16-22.
29. Leeflang MM, Rutjes AW, Reitsma JB, et al. Variation of a test's sensitivity and specificity with disease prevalence. Can Med Assoc J. 2013;185:E537-E544.
30. Mallett S, Halligan S, Thompson M, et al. Interpreting diagnostic accuracy studies for patient care. BMJ. 2012;345:e3999.
31. Chen SY, Chen YC, Chiang WC, et al. Field performance of clinical case definitions for influenza screening during the 2009 pandemic. Am J Emerg Med. 2012;30:1796-1803.
32. Huang PY, Huang CT, Tsao KC, et al. Syndromic recognition of influenza A infection in a low prevalence community setting. PLoS One. 2010;5:e10542.
33. Lee CS, Lee JH, Kim CH. Time-dependent sensitivity of a rapid antigen test in patients with 2009 H1N1 influenza. J Clin Microbiol. 2011;49:1702.
34. Wu UI, Wang JT, Chen YC, et al. Severity of pandemic H1N1 2009 influenza virus infection may not be directly correlated with initial viral load in upper respiratory tract. Influenza Other Respir Viruses. 2012;6:367-373.
35. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children: diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003-1032.
36. Chartrand C, Leeflang MM, Minion J, et al. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156:500-511.
37. Wang CB, Chiu ML, Lin PC, et al. Prompt oseltamivir therapy reduces medical care and mortality for patients with influenza infection: an Asian population cohort study. Medicine (Baltimore). 2015;94:e1070.